On August 1, 2025, Silexion Therapeutics Corp reported that they entered into an agreement to encourage holders of certain warrants to exercise their warrants at a reduced price of $11.57 per share, aiming to raise approximately $1.8 million for corporate purposes. The deal includes issuing new warrants for future share purchases at $11.32 per share.